Author | Brian Miller, MD, PhD, MPH

Articles

The Need for Speed

June 04, 2020

Article

Psychomotor speed may be a relevant target in studies of the immune system and its impact on the brain in patients with schizophrenia.

Is Esketamine Augmentation a Win for Depression?

June 04, 2020

Article

Last year, the FDA approved esketamine, a rapidly acting adjunctive intranasal therapy for treatment-resistant depression. Now, researchers are exploring its efficacy in major depressive disorder.

Getting the Dose Just Right

June 04, 2020

Article

There is inadequate information regarding optimal antipsychotic doses in the treatment of acute schizophrenia that balance efficacy and safety. This article helps you get it right.

What's In Your Mouth?

May 09, 2020

Article

The role of the oropharyngeal microbiome in schizophrenia and mania.

Clozapine for The Ages?

May 08, 2020

Article

New (and not-so-new) insights on antipsychotics across a range of different measures of treatment response.

Are the Eyes a Window Into the Mind of Schizophrenia?

March 10, 2020

Article

Recently, the use of spectral-domain optical coherence tomography has contributed to our understanding of retinal abnormalities in schizophrenia.

Antipsychotic Dosing in Acute Schizophrenia

March 10, 2020

Article

Information on minimum and maximum effective doses has great clinical utility, and new findings provide guidance.

Drug Psychosis May Pull the Schizophrenia Trigger

February 04, 2020

Article

A study examining the connection between substance-induced psychosis and subsequent diagnosis of schizophrenia or schizoaffective disorder provides key implications for treatment.

To Scan or Not to Scan: Brain Imaging in First-Episode Psychosis

February 04, 2020

Article

An important clinical conundrum in the diagnosis of new-onset psychosis is the role of neuroimaging to rule out medically or surgically treatable causes of illness.

Family History of Diabetes: Is There an Association With Nonaffective Psychosis?

January 31, 2020

Article

New insights on the association between family history of type 2 diabetes and comorbid diabetes in patients with schizophrenia and other nonaffective psychoses.

x